Alphaviruses in Gene Therapy
AbstractAlphavirus vectors present an attractive approach for gene therapy applications due to the rapid and simple recombinant virus particle production and their broad range of mammalian host cell transduction. Mainly three types of alphavirus vectors, namely naked RNA, recombinant particles and DNA/RNA layered vectors, have been subjected to preclinical studies with the goal of achieving prophylactic or therapeutic efficacy, particularly in oncology. In this context, immunization with alphavirus vectors has provided protection against challenges with tumor cells. Moreover, alphavirus intratumoral and systemic delivery has demonstrated substantial tumor regression and significant prolonged survival rates in various animal tumor models. Recent discoveries of the strong association of RNA interference and disease have accelerated gene therapy based approaches, where alphavirus-based gene delivery can play an important role. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Lundstrom, K. Alphaviruses in Gene Therapy. Viruses 2015, 7, 2321-2333.
Lundstrom K. Alphaviruses in Gene Therapy. Viruses. 2015; 7(5):2321-2333.Chicago/Turabian Style
Lundstrom, Kenneth. 2015. "Alphaviruses in Gene Therapy." Viruses 7, no. 5: 2321-2333.